Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Tafluprost (S01Ee05) As Part Of A So-Called Open House Model.

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 80910367

  Document Type - Tender Notices

Description - Description: Conclusion of non-exclusive discount contracts in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for drugs with the active ingredient tafluprost (S01EE05) within the period from June 1st, 2024 to May 31st, 2026 with the possibility of concluding a contract at any time (open-house model ). In the open house procedure, medicines according to the BfArM list according to Section 35 Para. 5a SGB V (childrens medicines) are excluded.local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Tafluprost (S01EE05) im Rahmen eines sogenannten Open-House-Modells.type_of_procedure: Otherbidding_res

Gt Ref Id - 80910367

Deadline - Mar 31, 2026